Be careful who you trust with your DNA
In the current unregulated genomics industry, we should think long and hard before granting industry access to our genetic information
We recently learned of the expansion of Genomics Medicine Ireland (GMI), with its ambitious goal to read the genome of 400,000 Irish people.
Most analysis has focused less on the undertaking itself than on the much-vaunted creation of 600 new jobs in a €350 million investment. But should we temper our enthusiasm with a modicum of caution?
Answering this question requires some background, which pertains to the wider industry as opposed to any individual company.
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Potential use of rapid antigen tests in workplaces and schools to be assessed
Speedy tests for virus could be used alongside the state’s PCR testing programme as country aims for safer eventual reopening
‘The next few weeks will give us hope if we can hang in there’
There are still some clouds on the horizon with the threat of new variants, but there is also hope as health workers report real benefits from the rollout of the Covid-19 vaccines
Lifting of ban on visits to nursing homes now urged
Geriatric specialists say vaccination has reduced the risk hugely, and that leaving the elderly to die alone in homes is ‘inhumane’
Deforestation, the wildlife trade and intensive farming: a recipe for lethal virus outbreaks
Conditions in the Wuhan market may have been an ‘early amplifier’ of the Covid-19 virus. Habitat destruction, the intensification of agriculture, global travel and climate change will be among the main factors in the emergence of even more deadly diseases, experts warn, as ‘we push nature to its limit’
